Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.
Superagonistic CD28-specific monoclonal antibodies (CD28SA) are highly effective activators of regulatory T-cells (Treg cells) in rats, but a first-in-man trial of the human CD28SA TGN1412 resulted in an unexpected cytokine release syndrome. Using a novel mouse anti-mouse CD28SA, we re-investigate t...
Main Authors: | Tea Gogishvili, Daniela Langenhorst, Fred Lühder, Fernando Elias, Karin Elflein, Kevin M Dennehy, Ralf Gold, Thomas Hünig |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2645706?pdf=render |
Similar Items
-
Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist Stimulation
by: Daniela Langenhorst, et al.
Published: (2018-01-01) -
CD28 Costimulation of T Helper 1 Cells Enhances Cytokine Release In Vivo
by: Daniela Langenhorst, et al.
Published: (2018-05-01) -
CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade
by: Karl-Gösta Sundqvist
Published: (2021-04-01) -
A novel mouse model for systemic cytokine release upon treatment with a superagonistic anti-CD28 antibody
by: Haack, Stephanie
Published: (2021) -
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies.
by: Zoe Waibler, et al.
Published: (2008-01-01)